Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1872]

Modern antiematogenic therapy from 5-HT3 to NK-1 antagonists

Dr Sayeh Lavasani - Memorial Cancer Institute, Hollywood, Florida, USA

Modern antiematogenic therapy from 5-HT3 to NK-1 antagonists ( Dr Sayeh Lavasani - Memorial Cancer Institute, Hollywood, Florida, USA )

The steady progress of targeted therapies

Dr Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands

The steady progress of targeted therapies ( Dr Anton Berns - Netherlands Cancer Institute, Amsterdam, Netherlands )

DNA repair and mutations as targets for personalised therapy

Prof Zoltan Szallasi - Boston Children's Hospital, Boston, USA

DNA repair and mutations as targets for personalised therapy ( Prof Zoltan Szallasi - Boston Children's Hospital, Boston, USA )

Obesity promotes pancreatic cancer progression and resistance

Dr Joao Incio - Massachusetts General Hospital, Boston, USA

Obesity promotes pancreatic cancer progression and resistance ( Dr Joao Incio - Massachusetts General Hospital, Boston, USA )

ERß expression predicts breast cancer risk in hyperplasia

Dr Tina Hieken - Mayo Clinic, Rochester, USA

ERß expression predicts breast cancer risk in hyperplasia ( Dr Tina Hieken - Mayo Clinic, Rochester, USA )

Polygenic risk and the targeted prevention of cancer

Prof Paul Pharoah - University of Cambridge, Cambridge, UK

Polygenic risk and the targeted prevention of cancer ( Prof Paul Pharoah - University of Cambridge, Cambridge, UK )

'Rewiring' tumour susceptibility

Dr Michael Yaffe - MIT, Cambridge, USA

'Rewiring' tumour susceptibility ( Dr Michael Yaffe - MIT, Cambridge, USA )

Personalising breast cancer therapy

Dr Funda Meric-Bernstam - University of Texas MD Anderson Cancer Center...

Personalising breast cancer therapy ( Dr Funda Meric-Bernstam - University of Texas MD Anderson Cancer Center, Houston, USA )

Results of the MINDACT clinical trial

Dr Suzette Delaloge - Institut Gustave Roussy, Paris, France

Results of the MINDACT clinical trial ( Dr Suzette Delaloge - Institut Gustave Roussy, Paris, France )

Breast and cervical cancer rates influenced by HRT, not contraceptive pill

Prof Valerie Beral - University of Oxford, Oxford, UK

Breast and cervical cancer rates influenced by HRT, not contraceptive pill ( Prof Valerie Beral - University of Oxford, Oxford, UK )

Implementing strategies to prevent cancer

Dr Graham Colditz - Washington University in St. Louis, St. Louis, USA

Implementing strategies to prevent cancer ( Dr Graham Colditz - Washington University in St. Louis, St. Louis, USA )

Halving cancer mortality

Prof Richard Peto - University of Oxford, Oxford, England

Halving cancer mortality ( Prof Richard Peto - University of Oxford, Oxford, England )

More from ecancer